OptumRx’s most recent pipeline outlook for 2020 reveals key therapeutic areas in the lineup.
Officials with the FDA have approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL.
A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.
Alkermes is seeking FDA approval for its investigational antipsychotic drug candidate ALKS 3831 for schizophrenia and bipolar I disorder.
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
How the pharmacy team at Novant Health Brunswick Medical Center ensured patients got their medications during Hurricane Florence.
If approved, dupilumab (Dupixent, Regeneron and Sanofi) would be indicated for use as an add-on maintenance treatment for children ages 6 to 11 years with moderate-to-severe atopic dermatitis.
Ticagrelor (Brilinta, AstraZeneca) reduced the risk of stroke and death when taken with aspirin compared with aspirin alone.
Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed.
Fidaxomicin (Dificid, Merck) is indicated in adults and pediatric patients aged 6 months and older for the treatment of Clostridioides difficile-associated diarrhea.